Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Debruyne

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bone Reports|July 2, 2026
MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitorsG Mammone, R Coropciuc, T Van den Wyngaert, et al.
European Journal of Cancer Care|January 29, 2014
Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of lifeL Pottel, M Lycke, T Boterberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2014
Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinomaR Elaidi, A Harbaoui, B Beuselinck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2023
Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201A Necchi, D Pouessel, R Leibowitz, et al.
Genes and Immunity|March 7, 2026
Immuno-molecular features and therapeutic implications of brain metastases in clear cell renal cell carcinoma patientsI Roodhooft, L Kinget, G Mammone, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 1, 2017
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitorsT van Cann, T Loyson, A Verbiest, et al.
Gynecologic Oncology|May 11, 2023
Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancerI Vergote, E Van Nieuwenhuysen, A Casado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2018
Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in BelgiumC Kenis, L Decoster, J Flamaing, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 5, 2018
Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgeryC Quinten, C Kenis, L Decoster, et al.
The Journal of Nutrition, Health & Aging|January 6, 2016
A Belgian Survey on Geriatric Assessment in Oncology Focusing on Large-Scale Implementation and Related Barriers and FacilitatorsC Kenis, P Heeren, L Decoster, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bone Reports|July 2, 2026
MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitorsG Mammone, R Coropciuc, T Van den Wyngaert, et al.
European Journal of Cancer Care|January 29, 2014
Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of lifeL Pottel, M Lycke, T Boterberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2014
Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinomaR Elaidi, A Harbaoui, B Beuselinck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2023
Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201A Necchi, D Pouessel, R Leibowitz, et al.
Genes and Immunity|March 7, 2026
Immuno-molecular features and therapeutic implications of brain metastases in clear cell renal cell carcinoma patientsI Roodhooft, L Kinget, G Mammone, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 1, 2017
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitorsT van Cann, T Loyson, A Verbiest, et al.
Gynecologic Oncology|May 11, 2023
Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancerI Vergote, E Van Nieuwenhuysen, A Casado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2018
Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in BelgiumC Kenis, L Decoster, J Flamaing, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 5, 2018
Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgeryC Quinten, C Kenis, L Decoster, et al.
The Journal of Nutrition, Health & Aging|January 6, 2016
A Belgian Survey on Geriatric Assessment in Oncology Focusing on Large-Scale Implementation and Related Barriers and FacilitatorsC Kenis, P Heeren, L Decoster, et al.
Pageof 2